secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001437749-23-018518
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 6M share increase under 2020 equity plan and adoption of 2023 ESPP
--------------------------------------------------------------------------------

- At June 21 annual meeting, stockholders approved amendment to 2020 equity incentive plan adding 6,000,000 shares.
- Stockholders approved the 2023 Employee Stock Purchase Plan.
- Elected directors Stephen S. Yoder, Michael Richman, and Matthew L. Sherman as Class III directors.
- Ratified Ernst & Young as independent auditor for FY2023; approved say-on-pay compensation on non-binding basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774923018518/0001437749-23-018518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774923018518/pirs20230622_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-018518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer